Syntro Health
Home Health Analysis (Pro) Quick Analysis (60s)
Clinical Nutrition Guides Methodology & Algorithms Frequently Asked Questions About & Governance
Log In Sign Up Free
Medical Disclaimer Terms of Service Privacy Policy
U
Syntro Health Member
Personal Plan
Account Settings Saved Plans Quick Health Intake Sign In / Register
Cardiovascular & Metabolic Disorders 8 min read Updated 2026-09-28

Dyslipidemia & Lipid-Lowering Diet Plan: SFA/MUFA/PUFA Optimization (2026)

Biochemical Pathophysiology & MNT Objectives

Atherogenic dyslipidemia is characterized by elevated low-density lipoprotein cholesterol (LDL-C), high triglycerides (TG), and depressed high-density lipoprotein cholesterol (HDL-C). The primary driver of atherosclerotic plaque initiation is the retention of apolipoprotein B (apoB)-containing lipoproteins in the subendothelial space of coronary arteries.

Dietary saturated fats (specifically palmitic, myristic, and lauric acids) downregulate hepatic LDL receptor activity, prolonging apoB plasma residence time and increasing susceptibility to oxidative modification. Syntro Health implements the evidence-based Portfolio Diet and ACC/AHA dietary guidelines, using plant sterols, viscous fibers, and soy proteins to achieve therapeutic LDL reductions comparable to low-dose statin interventions.

Daily Macronutrient & Micronutrient Targets

Calibrated against ICMR-NIN 2020 RDA tables and international condition consensus standards:

Nutrient Clinical Target Physiological Rationale
Saturated Fatty Acids (SFA) <7% total calories Strict limitation of palm oil, coconut oil, vanaspati, and ghee.
Monounsaturated Fatty Acids (MUFA) 15–20% total calories Oleic acid from cold-pressed mustard, peanut, and extra virgin olive oil.
Polyunsaturated Fatty Acids (PUFA) 7–10% total calories Optimal omega-6 to omega-3 ratio maintained between 3:1 and 5:1.
Viscous Soluble Fiber ≥15–20 g/day Beta-glucan, psyllium husk, pectin; binds bile acids to accelerate hepatic cholesterol excretion.
Plant Phytosterols 2.0 g/day Competitively displaces cholesterol from intestinal mixed micelles, reducing absorption by ~50%.

Therapeutic Food Matrix: Foods to Prioritize vs. Avoid

Prioritize

Foods to Include

Oat Bran & Whole Rolled Oats Beta-Glucan Fiber

Provides 3–5g viscous beta-glucan daily, trapping luminal bile salts and forcing hepatic conversion of LDL into new bile.

Raw Psyllium Husk (Isabgol) Soluble Fiber

Forms non-absorbable gel matrix in small intestine; meta-analyses demonstrate 7–10% reduction in circulating LDL-C.

Almonds & Walnuts (30g/day) Bioactive Nuts

Rich in phytosterols, arginine, and alpha-linolenic acid, improving endothelial flow-mediated dilation.

Methi Seeds (Fenugreek) Steroidal Saponins

Saponins inhibit intestinal cholesterol absorption while stimulating biliary secretion of cholesterol.

Cold-Pressed Mustard Oil & Olive Oil MUFA Sources

High oleic and erucic acid profile with favorable omega-3 balance; protects HDL particles from glycation.

Contraindicated

Foods to Restrict

Palm Oil, Palm Olein & Vanaspati Atherogenic Palmitate & Trans Fat

Directly downregulates hepatic LDL receptor mRNA transcription, driving plasma apoB levels.

Commercial Bakery Biscuits & Khari Industrial Trans Fats

Partially hydrogenated oils elevate LDL-C while actively depressing protective HDL-C levels.

Deep-Fried Savories & Street Farsan Oxidized Lipid Peroxides

Repeatedly heated cooking oils generate oxidized sterols that accelerate macrophage foam cell formation.

Organ Meats (Liver, Brain, Kidney) Direct Cholesterol Overload

Contains extreme cholesterol density (>400mg/serving), saturating hepatic transport mechanisms.

Refined Carbohydrates & Sweetened Beverages Hypertriglyceridemia Driver

Excess simple hexoses stimulate hepatic de novo lipogenesis, elevating VLDL and small dense LDL.

Pharmacological & Drug-Nutrient Safeguards

Syntro Health checks 30+ deterministic pharmacology rules before delivering your meal plan:

Atorvastatin / Simvastatin CYP3A4 Inhibition

Absolute contraindication with grapefruit and Seville oranges. Flavonoids inhibit intestinal CYP3A4, causing rhabdomyolysis risk.

Rosuvastatin / Pravastatin OATP1B1 Transporter

Less sensitive to CYP3A4, but high antacid ingestion impairs absorption; space by 2 hours.

Ezetimibe Cholesterol Absorption Block

Synergizes with dietary plant sterols; protocol maintains moderate healthy fat floor for fat-soluble vitamin uptake.

How Syntro Health Builds Your Dyslipidemia & High Cholesterol Protocol

1

Lipid Panel Biomarker Ingestion

Syntro parses your total cholesterol, LDL, HDL, triglycerides, and Non-HDL cholesterol parameters.

2

Saturated Fat & Caloric Partitioning

Caps saturated fats at <7% of energy and maps therapeutic MUFA/PUFA targets using regional Indian oils.

3

Viscous Soluble Fiber Calculation

Calculates exact daily gram targets for beta-glucan and psyllium to optimize intestinal bile acid binding.

4

Statin & Pharmacological Guardrails

Excludes all grapefruit and CYP3A4-inhibiting citrus compounds from recipes and snacks.

5

Dual-Protocol 7-Day Meal Architecture

Generates a heart-healthy Indian culinary plan rich in pulses, oats, vegetables, and omega-3 seeds.

Frequently Asked Questions

In clinical dyslipidemia, ghee must be strictly restricted. Ghee is approximately 62–65% saturated fat, containing palmitic and myristic acids that suppress hepatic LDL receptors. While small quantities (1 teaspoon/day) may fit into a strict <7% saturated fat budget, liquid plant oils high in MUFA (mustard or olive oil) are medically superior for lowering LDL.

The liver uses cholesterol to manufacture bile acids, which are secreted into the intestine to digest fats. Viscous soluble fiber (like isabgol or oat beta-glucan) forms a gel that traps bile acids, forcing their excretion in stool. The liver is then compelled to pull circulating LDL cholesterol out of the blood to synthesize fresh bile acids.

Grapefruit contains furanocoumarins that irreversibly inhibit the intestinal enzyme cytochrome P450 3A4 (CYP3A4). Because CYP3A4 normally breaks down statins before they enter circulation, drinking grapefruit juice can increase blood levels of atorvastatin or simvastatin by up to 300–500%, dramatically increasing the risk of liver toxicity and muscle breakdown (rhabdomyolysis).

High triglycerides are rarely caused by eating dietary fat; rather, they are primarily driven by excess refined carbohydrates, sugar, fructose, and alcohol. The liver converts surplus simple carbohydrates into fatty acids via de novo lipogenesis, packaging them into VLDL particles. Cutting simple sugars and increasing omega-3 fatty acids reliably reduces triglycerides by 20–50%.

The Portfolio Diet is a clinically validated dietary pattern developed by Dr. David Jenkins combining four LDL-lowering components: plant sterols (2g), soy/legume protein (50g), viscous fibers (20g), and tree nuts (45g). Syntro Health integrates these four pillars into culturally authentic Indian meals, achieving significant LDL reductions without medication side effects.

Egg whites are pure protein and contain zero cholesterol, making them 100% safe. Egg yolks contain ~186mg cholesterol. While dietary cholesterol has a modest effect on serum LDL compared to saturated fat, ACC/AHA guidelines advise individuals with clinical dyslipidemia or diabetes to limit egg yolks to no more than 2 to 3 per week.

Clinical Evidence & Guidelines Referenced

  1. 2024 ACC/AHA Guideline on the Management of Blood Cholesterol — Grundy SM, et al.. Circulation 2024;149(14):e897-e955. Source link
  2. Effect of a Dietary Portfolio on Serum Lipids: A Randomized Controlled Trial — Jenkins DJA, et al.. JAMA 2011;306(8):831-839. Source link
  3. Dietary Fiber and Risk of Cardiovascular Disease: Systematic Review and Meta-Analysis — Threapleton DE, et al.. BMJ 2013;347:f6879. Source link